Novel approaches for prevention of stroke related to transcatheter aortic valve implantation

References

• Leon MB, Smith CR, Mack M et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363(17), 1597–1607 (2010).
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364(23), 2187–2198 (2011).
   PubMed Web of Science ®Google Scholar
• Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics -- 2012 update: a report from the American Heart Association. Circulation 125(1), e2–e220 (2012).
   PubMed Web of Science ®Google Scholar
• Leon MB, Piazza N, Nikolsky E et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials. J. Am. Coll. Cardiol. 57(3), 17–17 (2011).
   Web of Science ®Google Scholar
• Brott T, Adams HP, Olinger CP et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20(7), 864–870 (1989).
   PubMed Web of Science ®Google Scholar
• Kappetein AP, Head SJ, Généreux P et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur. Heart J. 33(19), 2403–2418 (2012).
   PubMed Web of Science ®Google Scholar
• Makkar RR, Fontana GP, Jilaihawi H et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N. Engl. J. Med. 366(18), 1696–1704 (2012).
   PubMed Web of Science ®Google Scholar
• Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J. Med. 366(18), 1686–1695 (2012).
   PubMed Web of Science ®Google Scholar
• Khatri PJ, Webb JG, Rodés-Cabau J et al. Adverse effects associated with transcatheter aortic valve implantation: a meta-analysis of contemporary studies. Ann. Intern. Med. 158(1), 35–46 (2012).
   Web of Science ®Google Scholar
• Eggebrecht H, Schmermund A, Voigtländer T et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8(1), 129–138 (2012).
   PubMed Web of Science ®Google Scholar
• Nuis R-J, Van Mieghem NM, Schultz CJ et al. Frequency and causes of stroke during or after transcatheter aortic valve implantation. Am. J. Cardiol. 109(11), 1637–1643 (2012).
   PubMed Web of Science ®Google Scholar
• Tay EL, Gurvitch R, Wijesinghe N et al. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. JACC Cardiovasc. Interv. 4(12), 1290–1297 (2011).
   PubMed Web of Science ®Google Scholar
• Nombela-Franco L, Webb JG, de Jaegere PP et al. Timing, predictive factors, and prognostic value of cerebrovascular events in a large cohort of patients undergoing transcatheter aortic valve implantation. Circulation 126(25), 3041–3053 (2012).
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Mather AN, Bijsterveld P et al. Diffusion-weighted MRI determined cerebral embolic infarction following transcatheter aortic valve implantation: assessment of predictive risk factors and the relationship to subsequent health status. Heart 98(1), 18–23 (2011).
   PubMed Web of Science ®Google Scholar
• Omran H, Schmidt H, Hackenbroch M et al. Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet 361(9365), 1241–1246 (2003).
   PubMed Web of Science ®Google Scholar
• Kahlert P, Knipp SC, Schlamann M et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7), 870–878 (2010).
   PubMed Web of Science ®Google Scholar
• Ghanem A, Müller A, Nähle CP et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. J. Am. Coll. Cardiol. 55(14), 1427–1432 (2010).
   PubMed Web of Science ®Google Scholar
• Rodés-Cabau J, Dumont E, Boone RH et al. Cerebral embolism following transcatheter aortic valve implantation. J. Am. Coll. Cardiol. 57(1), 18–28 (2011).
   PubMed Web of Science ®Google Scholar
• Kahlert P, Al-Rashid F, Döttger P et al. Cerebral embolization during transcatheter aortic valve implantation: a transcranial Doppler study. Circulation 126(10), 1245–1255 (2012).
   PubMed Web of Science ®Google Scholar
• Erdoes G, Basciani R, Huber C et al. Transcranial Doppler-detected cerebral embolic load during transcatheter aortic valve implantation. Eur. J. Cardiothorac. Surg. 41(4), 778–774 (2012).
   PubMed Web of Science ®Google Scholar
• Kaireviciute D, Aidietis A, Lip GY. Atrial fibrillation following cardiac surgery: clinical features and preventative strategies. Eur. Heart J. 30(4), 410–425 (2009).
   PubMed Web of Science ®Google Scholar
• Almassi GH, Schowalter T, Nicolosi AC et al. Atrial fibrillation after cardiac surgery: a major morbid event? Ann. Surg. 226(4), 501–511 (1997).
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Rodés-Cabau J, Urena M et al. Incidence, Predictive Factors, and Prognostic Value of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Implantation. J. Am. Coll. Cardiol. 59(2), 178–188 (2012).
   PubMed Web of Science ®Google Scholar
• Adam N, Kandelman S, Mantz J, Chrétien F, Sharshar T. Sepsis-induced brain dysfunction. Expert Rev. Anti Infect. Ther. 11(2), 211–221 (2013).
   PubMed Web of Science ®Google Scholar
• Knipp SC, Kahlert P, Jokisch D et al. Cognitive function after transapical aortic valve implantation: a single-centre study with 3-month follow-up. Interact. Cardiovasc. Thorac. Surg. 16(2), 116–122 (2013).
   PubMed Web of Science ®Google Scholar
• Ghanem A, Müller A, Sinning J-M et al. Prognostic value of cerebral injury following transfemoral aortic valve implantation. EuroIntervention 8(11), 1294–1306 (2013).
   Web of Science ®Google Scholar
• Georgiadou P, Sbarouni E, Karavolias GK, Voudris V. Transcatheter aortic valve implantation: restoring the qualities of life in old age. Age Ageing 42(1), 21–26 (2012).
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Lei Y, Leon MB. Health-related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosisclinical perspective. Circulation 124(18) 1964–1972 (2011).
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Magnuson EA, Wang K et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J. Am. Coll. Cardiol. 60(6), 548–558 (2012).
   PubMed Web of Science ®Google Scholar
• Stortecky S, Schmid V, Windecker S et al. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. EuroIntervention 8(4), 437–443 (2012).
   PubMed Web of Science ®Google Scholar
• Fairbairn TA, Meads DM, Mather AN et al. Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J. Am. Coll. Cardiol. 59(19), 1672–1680 (2012).
   PubMed Web of Science ®Google Scholar
• Knipp SC, Matatko N, Schlamann M et al. Small ischemic brain lesions after cardiac valve replacement detected by diffusion-weighted magnetic resonance imaging: relation to neurocognitive function. Eur. J. Cardiothorac. Surg. 28(1), 88–96 (2005).
   PubMed Web of Science ®Google Scholar
• Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol. 6(7), 611–619 (2007).
   PubMed Web of Science ®Google Scholar
• Böttiger BW, Möbes S, Glätzer R et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 103(22), 2694–2698 (2001).
   PubMed Web of Science ®Google Scholar
• Oh SH, Lee JG, Na SJ, Park JH, Choi YC, Kim WJ. Prediction of early clinical severity and extent of neuronal damage in anterior-circulation infarction using the initial serum neuron-specific enolase level. Arch. Neurol. 60(1), 37–41 (2002).
   Google Scholar
• Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin. Chem. Lab. Med. 43(11), 1215–1217 (2005).
   PubMed Web of Science ®Google Scholar
• Reinsfelt B, Westerlind A, Ioanes D, Zetterberg H, Fredén-Lindqvist J, Ricksten SE. Transcranial Doppler microembolic signals and serum marker evidence of brain injury during transcatheter aortic valve implantation. Acta Anaesthesiol. Scand. 56(2), 240–247 (2012).
   PubMed Web of Science ®Google Scholar
• Patti G, Tomai F, Melfi R et al. Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting: results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study. J. Am. Coll. Cardiol. 61(13), 1379–1387 (2013).
   PubMed Web of Science ®Google Scholar
• Stortecky S, Windecker S. Stroke an infrequent but devastating complication in cardiovascular interventions. Circulation 126(25), 2921–2924 (2012).
   PubMed Web of Science ®Google Scholar
• Bagur R, Rodés-Cabau J, Doyle D. Transcatheter aortic valve implantation with “no touch” of the aortic arch for the treatment of severe aortic stenosis associated with complex aortic atherosclerosis. J. Card. Surg. 25(5), 501–503 (2010).
   PubMed Web of Science ®Google Scholar
• Grube E, Naber C, Abizaid A. Feasibility of transcatheter aortic valve implantation without balloon pre-dilation: a pilot study. JACC Cardiovasc. Interv. 4(7), 751–757 (2011).
   PubMed Web of Science ®Google Scholar
• Garg N, Karagiorgos N, Pisimisis GT, Sohal D. Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: a systematic review of the current literature. J. Endovasc. Ther. 16(2), 412–427 (2009).
   PubMedGoogle Scholar
• Onsea K, Agostoni P, Samim M et al. First-in-man experience with a new embolic deflection device in transcatheter aortic valve interventions. EuroIntervention 8(1), 51–56 (2012).
   PubMed Web of Science ®Google Scholar
• Nietlispach F, Wijesinghe N, Gurvitch R et al. An embolic deflection device for aortic valve interventions. JACC Cardiovasc. Interv. 3(11), 1133–1138 (2010).
   PubMed Web of Science ®Google Scholar
• Naber CK, Ghanem A, Abizaid AA et al. First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation. EuroIntervention 8(1), 43–50 (2012).
   PubMed Web of Science ®Google Scholar
• Van Mieghem NM, Schipper ME, Ladich E et al. Histopathology of embolic debris captured during transcatheter aortic valve replacement. Circulation 127(22), 2194–2201 (2013).
   PubMed Web of Science ®Google Scholar
• Wann LS, Curtis AB, January CT et al. 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practise Guidelines. J. Am. Coll. Cardiol. 57(2), 223–242 (2011).
   PubMed Web of Science ®Google Scholar
• Mitchell LB, CCS Atrial Fibrillation Guidelines Committee. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention and treatment of atrial fibrillation following cardiac surgery. Can. J. Cardiol. 27(1), 91–97 (2011).
   PubMed Web of Science ®Google Scholar
• Healey JS, Connolly SJ, Gold MR et al. Subclinical Atrial Fibrillation and the Risk of Stroke. N. Engl. J. Med. 366, 120–129 (2012).
   PubMed Web of Science ®Google Scholar
• Gherli T, Colli A, Fragnito C et al. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study. Circulation 110(5), 496–500 (2004).
   PubMed Web of Science ®Google Scholar
• Mistiaen W, Van Cauwelaert P, Muylaert P, Sys SU, Harrisson F, Bortier H. Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis. J. Thorac. Cardiovasc. Surg. 127(4), 1166–1170 (2004).
   PubMed Web of Science ®Google Scholar
• Toni D, Fiorelli M, Bastianello S et al. Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome. Neurology 46(2), 341–345 (1996).
   PubMed Web of Science ®Google Scholar
• Bonow RO, Carabello BA, Chatterjee K et al. ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J. Am. Coll. Cardiol. 48(3), e1–e148 (2006).
   PubMedGoogle Scholar
• Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 33(19), 2451–2496 (2012).
   PubMed Web of Science ®Google Scholar
• Mérie C, Køber L, Skov Olsen P et al. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 308(20), 2118–2125 (2012).
   PubMed Web of Science ®Google Scholar
• Lange R, Bleiziffer S, Mazzitelli D et al. Improvements in transcatheter aortic valve implantation outcomes in lower surgical risk patients. J. Am. Coll. Cardiol. 59(3), 280–287 (2012).
   PubMed Web of Science ®Google Scholar
• Wenaweser P, Stortecky S, Schwander S et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur. Heart J. 34(25), 1894–1905 (2013).
   PubMed Web of Science ®Google Scholar
• Dewilde WJ, Oirbans T, Verheugt FW et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet 381(9872), 1107–1115 (2013)
   PubMed Web of Science ®Google Scholar
• Dans AL, Connolly SJ, Wallentin L et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation 127(5), 634–640 (2013)
   PubMed Web of Science ®Google Scholar
• Sinning JM, Hammerstingl C, Vasa-Nicotera M et al. Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection. EuroIntervention 8(5), 640–641 (2012).
   PubMed Web of Science ®Google Scholar